KRAS and SP1 were borderline significant (HR 4.7, p 0.07 and 4.9, p 0.09, respectively), which both were associated with poor survival when highly expressed.
← all excerpts
Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers.
1
—
—